Back to Search
Start Over
T-score as an Indicator of Fracture Risk on Therapy: Evidence From Romosozumab vs Alendronate Treatment in the ARCH Trial
- Source :
- Osteologie; February 2020, Vol. 29 Issue: 1
- Publication Year :
- 2020
Details
- Language :
- English
- ISSN :
- 10191291
- Volume :
- 29
- Issue :
- 1
- Database :
- Supplemental Index
- Journal :
- Osteologie
- Publication Type :
- Periodical
- Accession number :
- ejs53819603
- Full Text :
- https://doi.org/10.1055/s-0039-3402889